T-Cell Responses Induced by an Intradermal BNT162b2 mRNA Vaccine Booster Following Primary Vaccination with Inactivated SARS-CoV-2 Vaccine

T-Cell Responses Induced by an Intradermal BNT162b2 mRNA Vaccine Booster Following Primary Vaccination with Inactivated SARS-CoV-2 Vaccine

A practical booster vaccine is urgently needed to control the coronavirus disease (COVID-19) pandemic. We have previously reported the safety and immunogenicity of a fractional intradermal booster, using the BNT162b2 mRNA vaccine in healthy volunteers who had completed two doses of inactivated SARS-...

Full description

Bibliographic Details
Main Authors: Ratchanon Sophonmanee, Jomkwan Ongarj, Bunya Seeyankem, Purilap Seepathomnarong, Porntip Intapiboon, Smonrapat Surasombatpattana, Supattra Uppanisakorn, Pasuree Sangsupawanich, Sarunyou Chusri, Nawamin Pinpathomrat
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Vaccines
Subjects:
intradermal
mRNA vaccine
inactivated SARS-CoV-2
COVID-19
T-cells
Online Access:https://www.mdpi.com/2076-393X/10/9/1494

Internet

https://www.mdpi.com/2076-393X/10/9/1494

Similar Items